- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Strong drug sales allow the German group to increase its full-year earnings forecast, while wilting crop science revenue pose more questions about the wisdom of buying Monsanto.
U.K. lender Lloyds falls after a third-quarter profit miss, while luxury goods maker Kering surges.
Index funds are great, Jim Cramer says, but he encourages investors to do some smart stock picking.